Skip to main content
PMC home page
Springer logoLink to Springer
. 2021 Nov 3;40(2):463. doi: 10.1007/s10637-021-01194-3

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study

Kyaw Z Thein 1,2,✉, Daniel D Karp 1, Apostolia Tsimberidou 1, Jing Gong 1, Selma Sulovic 1, Jatin Shah 3, Denái R Milton 4, David S Hong 1, Filip Janku 1, Lacey McQuinn 1, Bettzy A Stephen 1, Rivka Colen 5, Brett W Carter 6, Timothy A Yap 1, Sarina A Piha‑Paul 1, Siqing Fu 1, Funda Meric‑Bernstam 1, Aung Naing 1,6
PMCID: PMC8993707  PMID: 34731355

Correction to: Investigational New Drugs https://doi.org/10.1007/s10637-021–01188-1

The article Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single‑center, multi‑arm phase Ib study was originally published electronically on the publisher’s internet portal on 25 September 2021 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2021 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Investigational New Drugs are provided here courtesy of Springer

RESOURCES